Actavia Life Sciences, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Actavia Life Sciences, Inc. (RASP) is 521.89K

According to Actavia Life Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 521.89K. This represents a change of -95.21% compared to the average of 10.90M of the last 4 quarters.

Actavia Life Sciences, Inc. (RASP) Historical Enterprise Value (quarterly & annually)

How has RASP Enterprise Value performed in the past?

The mean historical Enterprise Value of Actavia Life Sciences, Inc. over the last ten years is 8.78M. The current 521.89K Enterprise Value has changed -94.06% with respect to the historical average. Over the past ten years (40 quarters), RASP's Enterprise Value was at its highest in in the September 2017 quarter at 269.77M. The Enterprise Value was at its lowest in in the December 2022 quarter at 1.28M.

Actavia Life Sciences, Inc. (RASP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Actavia Life Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Actavia Life Sciences, Inc. (RASP) Average Enterprise Value

How has RASP Enterprise Value performed in the past?

The current Enterprise Value of Actavia Life Sciences, Inc. (RASP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Actavia Life Sciences, Inc. (RASP) Enterprise Value vs. Peers

How is RASP’s Enterprise Value compared to its peers?

Actavia Life Sciences, Inc.’s Enterprise Value is less than ChitogenX Inc. (4.26M), greater than Wesana Health Holdings Inc. (206.43K), greater than Innovation Pharmaceuticals Inc. (-690197.00), less than Tevano Systems Holdings Inc (1.37M), greater than Lift & Co. Corp. (-551641.32), greater than Nascent Biotech, Inc. (-215177.00), less than Viracta Therapeutics, Inc. (13.63M), less than RespireRx Pharmaceuticals Inc. (3.37M), greater than MedGen, Inc. (90.33K), less than Paradigm Medical Industries, Inc. (2.19M),

Build a custom stock screener for Actavia Life Sciences, Inc. (RASP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Actavia Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Actavia Life Sciences, Inc. (RASP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Actavia Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.